The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
University of California, Irvine
ViroMissile, Inc.
Institut Curie
Perspective Therapeutics
Eli Lilly and Company
UNICANCER
University of Illinois at Chicago
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
British Columbia Cancer Agency
Washington University School of Medicine
Turning Point Therapeutics, Inc.
University of California, Irvine
Cancer Research UK
Elevation Oncology
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Cyteir Therapeutics, Inc.
University of California, Davis
Taiho Pharmaceutical Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
Innolake Biopharm
Presage Biosciences
Pfizer
Adaptimmune
Emory University
Kineta Inc.
Shanghai Yunying Medical Technology
Prelude Therapeutics
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Presage Biosciences
Oncovir, Inc.
University Hospital Tuebingen
Tocagen Inc.
Eli Lilly and Company
Stanford University
Mie University
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota